OpenResearchAlpha

Journal of the American Heart Association · 4 Nov 2026

Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study

Joshua D. Mitchellh-index 29, Margarita Udall, Liana Hennum, Hanh Dung Dao, Bret Zeldow, Elizabeth Nagelhout, Kevin M. Alexanderh-index 18, Richard K. Chengh-index 37

1
Citations
Crossref's count; others 0
0
Citations in 2026
so far
37
Leading author's h-index
Richard K. Cheng, in QAI's scholar index
43
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • Crossref1
  • OpenCitations0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Background Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a progressive, life‐threatening condition. Timely and accurate diagnosis remains a challenge. We assessed time from first recorded clinical manifestation to ATTR‐CM diagnosis in the United States and characterized manifestations associated with diagnostic delays. Methods Retrospective analysis of US claims data (Komodo Healthcare Map, July 1, 2016–June 30, 2024). Patients were required to have ≥3 years of continuous enrollment before diagnosis. Results Among 7509 patients, mean age 75.9 years, 63.2% male, 54.5% White, and 28.6% Black. Patients had a median of 8 manifestations before diagnosis; median observed time from first recorded manifestation to diagnosis was 5.2 years, shorter for variant versus wild‐type ATTR‐CM (4.4 versus 5.2 years). Within 3 years before diagnosis, patients had a mean of 12.04 (95% CI, 11.75–12.35) primary care physician visits and 14.45 (95% CI, 14.10–14.80) specialists of interest visits, most commonly with cardiologists and ophthalmologists. In adjusted analyses, variant ATTR‐CM was associated with shorter time to diagnosis (β, −0.41 years [95% CI, −0.56 to −0.26]), whereas comorbidities, including hypertension (β, 0.46 years [95% CI, 0.27–0.64]), were associated with longer delays. Conclusions The diagnostic trajectory for ATTR‐CM can be prolonged and challenging, leading to more advanced disease at diagnosis and increased burden. Raising awareness may provide an opportunity for earlier diagnosis.

What the data shows

  • Crossref counts 1 citations, the most of the databases. The others count 0.
  • Richard K. Cheng has the highest h-index among the authors (37).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (8)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (43)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 23 more references

A free account opens the rest of the citing papers and references on every paper’s page.